|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $37 and $64 | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment: | ||||||||||||||||||||
| Computer software | ||||||||||||||||||||
| Office furniture and equipment | ||||||||||||||||||||
| Laboratory equipment | ||||||||||||||||||||
| Leasehold improvements | ||||||||||||||||||||
| Total Property and equipment | ||||||||||||||||||||
| Accumulated depreciation and amortization | ||||||||||||||||||||
| Total Property and Equipment, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Finance lease right-of-use asset, net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Insurance note payable | ||||||||||||||||||||
| Equipment financing debt | ||||||||||||||||||||
| Current portion of finance lease liability | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred tax liabilities, long-term | ||||||||||||||||||||
| Long-term portion of operating lease liabilities | ||||||||||||||||||||
| Long-term portion of finance lease liability | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Preferred stock, $0.005 par value, 873 shares authorized, no shares issued or outstanding | ||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share (in dollars per share) | ||||||||||||||||||||
| Common stock, $0.005 par value; 50,000 shares authorized, 6,778 shares and 6,474 shares issued at December 31, 2024 and 2023, respectively, 6,110 shares outstanding and 5,806 shares outstanding at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Less - Treasury stock, at cost, 668 shares | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity |
Loading...
